Table:
begin	end	state
1	5	non-cytoplasmic
6	34	transmembrane
35	45	cytoplasmic
46	68	transmembrane
69	100	non-cytoplasmic
101	122	transmembrane
123	133	cytoplasmic
134	157	transmembrane
158	168	non-cytoplasmic
169	193	transmembrane
194	213	cytoplasmic
214	234	transmembrane
235	239	non-cytoplasmic
240	258	transmembrane
259	269	cytoplasmic
270	291	transmembrane
292	299	non-cytoplasmic
300	325	transmembrane
326	331	cytoplasmic
332	350	transmembrane
351	356	non-cytoplasmic
357	383	transmembrane
384	394	cytoplasmic
395	419	transmembrane
420	427	non-cytoplasmic

Input:
>WP_086510923.1 NCBI__GCF_002151265.1:WP_086510923.1
MEVMVLFGVFLLLLVLGLPIAFALGISSLAYLLLEGISLTIVPQRMYSGIDTFVLLCIPG
FVLAGNLMNVGNITEHIVRFSNAVVGHIRGGLGLANVGGSMIFGGISGTAVADAASIGSV
MIPGMARSGYDKPFAAAVTAASSTIGPIIPPSVPMIIVGSLAGVSVGRMFLAGAVPGLLL
GVAMMITVYLLAVKRGYPKGRRATLRELLREGRTAFWALLMTVIILYGIIGGFFTPTEAS
IVASLYALVVGMYVYKGLTWRKLPAILTDTVLTSSALLLLVGLANLFGWILTSQQIPQTI
AALIMAISDNPIVVILILNLILLFVGAFMETIAALIILFPALLGVATGIGMDPVHFAVMA
VLNLMIGLTTPPVGVCLFVVSGIGKLQMLTVARAILPFLVCNILVLLLVAYVPAISLWLP
DLLMGTR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server